Pangrol (Pancreas Powder)

Pancreas Powder is believed to provide a mixture of digestive enzymes such as amylase, lipase and proteases. When taken orally, these enzymes could aid the breakdown of carbohydrates, fats and proteins in the gastrointestinal tract. However, the precise pharmacological targets and the extent of enzymatic activity after ingestion have not been fully characterized in the public domain.

Dosing for Pangrol is determined by the prescribing healthcare professional based on the individual’s clinical situation, age, weight and any relevant laboratory parameters. Because there is no established dosing guideline in public references, the prescriber sets the appropriate amount and frequency for each patient.

Safety data for Pancreas Powder in pregnant or lactating women are lacking. In the absence of well‑controlled studies, the product should be avoided unless the potential benefit justifies the possible risk to the fetus or infant, and the decision should be made by a qualified obstetrician or pediatrician.

To request Pangrol, visit the product page on gnhindia.com, enter the desired quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Pangrol’s Pancreas Powder differs from standard pancreatic enzyme replacement therapies, which are typically formulated with defined amounts of specific enzymes (e.g., pancrelipase). Because Pangrol’s exact enzyme composition and potency are not publicly disclosed, direct efficacy comparisons are not possible. Clinicians usually prefer products with established dosing and regulatory approval for conditions such as exocrine pancreatic insufficiency.

Pangrol should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, excessive heat and direct sunlight. Do not refrigerate or freeze unless the manufacturer’s label specifically advises otherwise.

Pangrol is intended for oral administration. The powder should be taken with a glass of water, preferably during or immediately after a meal to maximize contact with ingested food. Patients should follow the prescribing clinician’s instructions regarding timing, dosage and any required dietary considerations.

The most serious potential risks include severe allergic reactions such as anaphylaxis, exacerbation of underlying pancreatitis, rare episodes of hypoglycemia and possible liver enzyme elevations. Patients should be instructed to seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or throat, sudden abdominal pain or jaundice.

Individuals with a known hypersensitivity to pancreatic extracts or any component of the formulation should avoid Pangrol. It is also contraindicated in patients with active severe pancreatitis, uncontrolled diabetes, or those who are pregnant or breastfeeding unless a specialist determines that the potential benefits outweigh the unknown risks.